Clin2
NCT06951880Likely a fitRecruiting

Safety of AZD4916 in healthy volunteers

Healthy Participants

This study tests a new drug called AZD4916 in healthy people to see if it's safe and how the body processes it. It may help decide if the drug is safe enough for future studies.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
160 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be a healthy adult between 18 and 55 years old (approximately).
  • Your body mass index (BMI) must be between 18 and 30, and you must weigh at least 45 kg.
  • If you are a woman able to have children, you must agree to use highly effective birth control and have a negative pregnancy test.
  • You cannot have any serious medical condition like heart, liver, kidney, or lung disease, or a history of cancer, tuberculosis, or HIV/hepatitis.
  • You must not smoke, abuse alcohol or drugs, or have donated blood recently.
  • If you are Japanese or Chinese, specific ancestry and residency requirements apply.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07290283Recruiting· Phase 1
Testing safety of AZD3974 in healthy volunteers

This trial tests a new medicine called AZD3974 in healthy people to see if it is safe and how the body handles it. It may help find the right dose for future studies.

Glendale, California
NCT06980428Recruiting· Phase 1
Safety study of AZD4954 in people with or without high Lp(a)

This trial tests a new drug called AZD4954 for safety. It includes healthy volunteers and people with high Lp(a) or dyslipidemia. The goal is to see if the drug is safe and how the body processes it.

Glendale, California
NCT07511205Recruiting· Phase 1
Study of AZD1043 for overweight or obesity

This trial tests a new medicine called AZD1043 in healthy adults who are overweight or have obesity. It aims to see if the medicine is safe and how the body handles it.

Glendale, California
NCT07745907Recruiting· Phase 1
A first-in-human study of a new drug in healthy Chinese and Japanese adults

This trial tests a single dose of an investigational drug called AMG 691 in healthy Chinese and Japanese volunteers to see how it is processed by the body and how safe it is. This is an early-phase study, so it may help make future treatments safer for people of similar backgrounds.

Las Vegas, Nevada
NCT07432698Not yet recruiting· Phase 1
Testing AK0406 injection safety in healthy volunteers

This study tests the safety and how the body processes a new drug called AK0406 in healthy adults. If you are generally healthy and match the age and weight requirements, you may be able to help researchers understand if the drug is safe before it is tested in people with a medical condition.

Bayswater, Victoria
NCT07463196Recruiting· Phase 1
Safety study of ACI-19764 in healthy adults

This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.

Groningen

Hear when a new Healthy Participants trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.